Research and Development
Research helps us develop new treatments, understand and prevent illnesses, and improve our patient’s quality of life.
We’re involved in a number of research projects in areas such as mental health, dementia, diabetes, sexual health, COPD and Coronavirus (COVID-19).
Last year, 1,494 people participated in our research, and our 2019/20 Participant Research Experience Survey showed that 96% of people who took part had a good experience, and 87% would help us again.
Get involved in our research studies
You can find more information about our latest studies and how to get involved on our website.
Find out about taking part in our studies
Contact us
Research and Development
Psychology Department
Room 161 First Floor
Harry Pitt Building, Earley Gate
Whiteknights Road
University of Reading
RG6 7BE
Call 0118 378 5264
Email research@berkshire.nhs.uk
Our research performance
We’re a research active Trust, which means we offer a greater number of opportunities to high quality research projects compared to other similar Trusts.
We regularly publish our clinical trial reports. Please contact us if you need to see a report from previous years.
Initiating clinical trials
Read our 2019-20 Q1 report on 'Performance in initiating Clinical Trials'
Read our 2019-20 Q2 report on 'Performance in initiating Clinical Trials'
Read our 2019-20 Q3 report on 'Performance in initiating Clinical Trials'
Read our 2019-20 Q4 report on 'Performance in initiating Clinical Trials'
Read our 2020-21 Q1 report on 'Performance in initiating Clinical Trials'
Read our 2020-21 Q2 report on 'Performance in initiating Clinical Trials'
Delivering clinical trials
Read our 2019-20 Q1 report on 'Performance in delivering Clinical Trials'
Read our 2019-20 Q2 report on 'Performance in delivering Clinical Trials'
Read our 2019-20 Q3 report on 'Performance in delivering Clinical Trials'
Read our 2019-20 Q4 report on 'Performance in delivering Clinical Trials'
Read our 2020-21 Q1 report on 'Performance in delivering Clinical Trials'
Read our 2020-21 Q2 report on 'Performance in delivering Clinical Trials'